Solitary keratoacanthoma of the lip vermilion: case report and comprehensive review of literature
DOI:
https://doi.org/10.5935/2525-5711.20190003Palabras clave:
Keratoacanthoma, Carcinoma, Squamous Cell, Lip, Neoplasm Regression, SpontaneousResumen
Solitary keratoacanthoma (S-KA) is a benign epithelial proliferation that affects the sun-exposed skin of elderly. It presents rapid growth often followed by spontaneous remission. S-KA clinical and microscopic features are very similar to the squamous cell carcinoma’s (SCC) and differentiating them can be a challenge. S-KA involving the lip is rare and frequently is managed as SCC, leading to overtreatment. Despite of few investigations aiming at differentiate S-KA and SCC are available, there is no compilation of case reports of lip S-KA. Thus, our aim was to conduct a comprehensive review of the literature and report a case of lip S-KA. The review was conducted until 2016 and only 21 cases were found. Lip S-KA was more common in elder man, lower lip, and most of them were asymptomatic. The lesions measured 16.7mm on average with duration of approximately 12 weeks. The most performed treatment was excisional biopsy of lesion despite of the self-healing potential of the lesion.
Citas
Azaz B, Lustmann J. Keratoacanthoma of the lower lip. Review of the literature and report of a case. Oral Surg Oral Med Oral Pathol. 1974;38(6):918-27.
Chaiben CL, Bohn JC, Kuczynski A, Gil FB, de Lima AA. Keratoacanthoma in the inferior lip of an immunosuppressed patient. A case report. Stomatologija. 2013;15(2):61-4.
Chauhan A, Chaudhary S, Agnihotri PG, Aadithya B. A solitary crateriform ulcer of the lower lip: a case report with review of literature. Indian J Dermatol. 2011;56(4):435-8.
de Visscher JG, van der Wal JE, Starink TM, Tiwari RM, van der Waal I. Giant keratoacanthoma of the lower lip. Report of a case of spontaneous regression. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(2):193-6.
de Visscher JG, van der Wal KG, Blanken R, Willemse F. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report. J Oral Maxillofac Surg. 2002;60(1):93-5.
Guimaraes EP, de Carli ML, Sperandio FF, Pereira AA, Hanemann JA. Giant keratoacanthoma of the lower lip: case report and review of the published literature. Gen Dent. 2016;64(1):22-5.
Gulati S, Pandiar D, Kakky S, Jiwane AY, Balan A. Keratoacanthoma of Upper Lip: Review and Report of Case Managed Surgically. J Clin Diagn Res. 2015;9(10):ZD08-10.
Karnauchow PN. A lesion simulating squamous carcinoma of the lip (keratoacanthoma). Can Med Assoc J. 1958;78(5):346-8.
Kohn MW, Eversole LR. Keratoacanthoma of the lower lip: report of cases. J Oral Surg. 1972;30(7):522-6.
Minicucci EM, Weber SA, Stolf HO, Marques ME, Ribeiro DA. Keratoacanthoma of the lower lip complicating discoid lupus erythematosus in a 14-year-old boy. Pediatr Dermatol. 2007;24(3):329-30.
Pinto-Almeida T, Oliveira A, da Cunha Velho G, Alves R, Caetano M, Selores M. Giant cutaneous horn on the lower lip. Dermatol Online J. 2011;17(12):10.
Ramos LM, Cardoso SV, Loyola AM, Rocha MA, Durighetto-Junior AF. Keratoacanthoma of the inferior lip: review and report of case with spontaneous regression. J Appl Oral Sci. 2009;17(3):262-5.
Spieth K, Gille J, Kaufmann R. Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip. Dermatology. 2000;200(4):317-9.
Whittle CH, Davis RA. Keratoacanthoma of lower-lip red margin. Lancet. 1957;272(6977):1019-20.
El-Hakim IE, Uthman MA. Squamous cell carcinoma and keratoacanthoma of the lower lip associated with "Goza" and "Shisha" smoking. Int J Dermatol. 1999;38(2):108-10.
Oh CK, Son HS, Lee JB, Jang HS, Kwon KS. Intralesional interferon alfa-2b treatment of keratoacanthomas. J Am Acad Dermatol. 2004;51(5 Suppl):S177-80.
Zargaran M, Baghaei F. A clinical, histopathological and immunohistochemical approach to the bewildering diagnosis of keratoacanthoma. J Dent (Shiraz). 2014;15(3):91-7.
D. Weedon, E. Haneke, M. Martinka, G.W. Elgart, R.J. Mortimore, Gross C, et al. Acanthomas. In: LeBoit PE, Burg Gn, Weedon D, Sarasin A, editors. Pathology & Genetics - Skin tumours. 1. Lyon: IARC Press; 2006. p. 44-7.
Gleich T, Chiticariu E, Huber M, Hohl D. Keratoacanthoma: a distinct entity? Exp Dermatol. 2016;25(2):85-91.
Clausen OP, Aass HC, Beigi M, Purdie KJ, Proby CM, Brown VL, et al. Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol. 2006;126(10):2308-15.
Lowes MA, Bishop GA, Cooke BE, Barnetson RS, Halliday GM. Keratoacanthomas have an immunosuppressive cytokine environment of increased IL-10 and decreased GM-CSF compared to squamous cell carcinomas. Br J Cancer. 1999;80(10):1501-5.
Sanchez Yus E, Simon P, Requena L, Ambrojo P, de Eusebio E. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant. Am J Dermatopathol. 2000;22(4):305-10.
Watanabe IC, Magalhaes RF, de Moraes AM, Stelini RF, Cintra GF, Metze K, et al. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis. Medicine (Baltimore). 2015;94(23):e934.
Aung PP, Ballester LY, Mahalingam M. Histopathology of Keratoacanthoma Revisited: Utility of Orificial Size as a Diagnostic Adjunct. Int J Surg Pathol. 2014;22(4):316-25.
Annest NM, VanBeek MJ, Arpey CJ, Whitaker DC. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. J Am Acad Dermatol. 2007;56(6):989-93.
Patel NP, Cervino AL. Treatment of keratoacanthoma: Is intralesional methotrexate an option? Can J Plast Surg. 2011;19(2):e15-8.
Grob JJ, Suzini F, Richard MA, Weiller M, Zarour H, Noe C, et al. Large keratoacanthomas treated with intralesional interferon alfa-2a. J Am Acad Dermatol. 1993;29(2 Pt 1):237-41.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 1969 Aneliza de Fatima Moraes da Silva, José Humberto Damante, Luiz Antônio Assis Taveira, Kellen Cristine Tjioe
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
